Biothera To Present Phase 2b NSCLC Data At ESMO 2014 European Lung Cancer Conference

Biothera will present data from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) at the European Society for Medical Oncology’s 2014 European Lung Cancer Conference on March 28 in Geneva, Switzerland.

The company will give a presentation about its randomized trial in patients with previously untreated advanced NSCLC evaluating Biothera’s immunotherapy drug, Imprime PGG®.

Help employers find you! Check out all the jobs and post your resume.